Prostate cancer patients with cardiovascular risk factors: long-term safety of abiraterone acetate

被引：0
|
作者：
Verzoni, E. [1 ]
Grassi, P. [1 ]
Ratta, R. [1 ]
Mennitto, A. [1 ]
Montone, R. [1 ]
Prisciandaro, M. [1 ]
de Braud, F. [1 ]
Procopio, G. [1 ]
机构：
[1] Fdn IRCSS Ist Nazl Tumori, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw334.20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C20
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors
    Verzoni, Elena
    Grassi, Paolo
    Ratta, Raffaele
    Niger, Monica
    De Braud, Filippo
    Valdagni, Riccardo
    Procopio, Giuseppe
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (05) : 323 - 330
  • [2] Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors
    Procopio, Giuseppe
    Grassi, Paolo
    Testa, Isabella
    Verzoni, Elena
    Torri, Valter
    Salvioni, Roberto
    Valdagni, Riccardo
    de Braud, Filippo
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (05): : 479 - 482
  • [3] Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation
    Prati, Veronica
    Ruatta, Fiorella
    Aversa, Caterina
    Gernone, Angela
    Galizia, Danilo
    Bonzano, Alessandro
    Torino, Sofia
    Nuzzolese, Imperia
    Marandino, Laura
    Aglietta, Massimo
    Ortega, Cinzia
    [J]. FUTURE ONCOLOGY, 2018, 14 (05) : 443 - 448
  • [4] Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer
    Chamorey, Emmanuel
    Pujalte-Martin, Marc
    Ferrero, Jean-Marc
    Mahammedi, Hakim
    Gravis, Gwenaelle
    Roubaud, Guilhem
    Beuzeboc, Philippe
    Largillier, Remy
    Borchiellini, Delphine
    Linassier, Claude
    Bouges, Helene
    Etienne-Grimaldi, Marie-Christine
    Schiappa, Renaud
    Gal, Jocelyn
    Milano, Gerard
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [5] CARDIOVASCULAR RISK FACTORS IN PATIENTS ON LONG-TERM TREATMENT
    Bellacosa, C.
    Altamura, M.
    Lenoci, F. D.
    Volpe, A.
    Perilli, F.
    Lillo, A.
    Angarano, G.
    Maggi, P.
    [J]. INFECTION, 2011, 39 : S60 - S60
  • [6] SAFETY OF ABIRATERONE ACETATE (AA) IN PATIENTS WITH CASTRATION RESISTANT PROSTATE CANCER (CRPC) AND CONCOMITANT CARDIAC RISK
    Procopio, G.
    Verzoni, E.
    Testa, I.
    Stagni, S.
    Villa, S.
    Valdagni, R.
    De Braud, F. G. M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 305 - 305
  • [7] ABIRATERONE ACETATE: PROSPECTIVE EVALUATION OF THE CARDIOVASCULAR SAFETY PROFILE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS
    Ruatta, Fiorella
    Prati, Veronica
    Aversa, Caterina
    Gernone, Angela
    Galizia, Danilo
    Bonzano, Alessandro
    Torino, Sofia
    Nuzzolese, Imperia
    Marandino, Laura
    Aglietta, Massimo
    Ortega, Cinzia
    [J]. ANTICANCER RESEARCH, 2016, 36 (05) : 2615 - 2615
  • [8] A drug safety evaluation of abiraterone acetate in the treatment of prostate cancer
    Castellan, Pietro
    Castellucci, Roberto
    Marchioni, Michele
    De Nunzio, Cosimo
    Tema, Giorgia
    Primiceri, Giulia
    Schips, Luigi
    Cindolo, Luca
    [J]. EXPERT OPINION ON DRUG SAFETY, 2019, 18 (09) : 759 - 767
  • [9] Safety of abiraterone acetate (AA) in castration-resistant prostate cancer (CRPC) patients with concomitant cardiovascular disease.
    Procopio, Giuseppe
    Verzoni, Elena
    Testa, Isabella
    Biasoni, Davide
    Torelli, Tullio
    Nicolai, Nicola
    Salvioni, Roberto
    Valdagni, Riccardo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [10] Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer
    Felicetti, F.
    D'Ascenzo, F.
    Brignardello, E.
    Moretti, C.
    Gaita, F.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 477 - 477
12345